Abstract
No public abstract is available from the verified source records.
Andrea R. Munafò, Giuseppe Esposito, Arif Khokhar, Stephanie Brunner, Sarah Verhemel, Alice Annalisa Cerutti, Sara Ceni, Damiano Regazzoli, Andrea Buono, Mattia Squillace, Stefano Nava, Andrea Sultana, José Luis Díez Gil, Omar Olivier, Andrea Scotti, Alessandro Mandurino-Mirizzi, David Bauer, Pablo Codner, Michelangelo Carbonara, Antonio Mangieri, Horst Sievert, Italo Porto, Petr Toušek, Dionigi Fischetti, Azeem Latib, Jorge Sanz Sanchez, Diego Maffeo, Francesco Bedogni, Bernhard Reimers, Nicholas Van Mieghem, Francesco Saia, Francesco Soriano, Jacopo A. Oreglia, Claudio Montalto
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Coronary artery disease and TAVI: current evidence on a recurrent issue
2023
Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry
10.1007/s00392-012-0486-5 · 2012
Transcatheter aortic valve implantation with complex, high-risk indicated PCI
10.4244/eij-e-25-00011 · 2025
Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement
10.1093/eurheartj/ehae019 · 2024
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation
10.4244/eij-d-23-00186 · 2023
The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis
10.4244/eijy14m05_09 · 2015
Outcomes of complex, high-risk percutaneous coronary intervention in patients with severe aortic stenosis: the ASCoP registry
10.4244/eij-d-24-00933 · 2025
Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research
10.1093/eurheartj/ehaa799 · 2021
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
10.1161/circulationaha.110.009449 · 2011
Standardized end point definitions for coronary intervention trials: the academic research Consortium-2 consensus document
10.1161/circulationaha.117.029289 · 2018
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
10.1002/sim.6607 · 2015
Statistical primer: propensity score matching and its alternatives
10.1093/ejcts/ezy167 · 2018
Severe aortic stenosis and coronary artery disease
2013
2025 ESC/EACTS Guidelines for the management of valvular heart disease
10.1093/eurheartj/ehaf194 · 2025
Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-art review
10.1016/j.jacc.2019.06.012 · 2019
Efficacy and safety of dual antiplatelet therapy after complex PCI
10.1016/j.jacc.2016.07.760 · 2016
Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study
10.1016/j.jcin.2020.07.006 · 2020
Coronary cannulation following TAVR using self-expanding devices with commissural alignment: the RE-ACCESS 2 study
10.1016/j.jcin.2023.12.015 · 2024
The coronary access after TAVI (CAvEAT) study: A prospective registry of CA after TAVR
10.1016/j.jcin.2025.05.002 · 2025
Timing and outcomes of percutaneous coronary intervention in patients who underwent transcatheter aortic valve implantation
10.1016/j.amjcard.2020.01.043 · 2020
ACTIVATION (PercutAneous coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial
10.1016/j.jcin.2021.06.041 · 2021
PCI in patients undergoing transcatheter aortic-valve implantation
10.1056/nejmoa2401513 · 2024
Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial
10.1016/s0140-6736(26)00308-9 · 2026
Timing of PCI in patients undergoing transcatheter aortic-valve implantation
10.1056/nejmoa2606924 · 2026
Clinical impact of myocardium at risk in transcatheter aortic valve implantation
10.1161/circinterventions.125.015770 · 2026
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial
10.1016/s0140-6736(18)31714-8 · 2018
10.4244/eij-d-22-00958
10.4244/eij-d-22-00958 · 2023
No additional external references are available.